Article

Corneal transplants use pre-loaded tissue

Cartridges pre-loaded by an eye bank (EndoGlide, Angiotech Pharmaceuticals Inc.) have been successfully used in corneal transplantation.

 

Tampa, FL-Cartridges pre-loaded by an eye bank (EndoGlide, Angiotech Pharmaceuticals Inc.) have been successfully used in corneal transplantation, according to the Lions Eye Institute for Transplant & Research (LEITR).

The cartridges were selected for initial endothelial keratoplasty transplant procedures utilizing donor endothelial tissue that was pre-cut, trephined, and pre-loaded into the device at LEITR in Tampa, FL.

The loaded cartridges were then transported to the Massachusetts Eye and Ear Infirmary, Boston, where the procedures were performed by Roberto Pineda II, MD, associate professor of ophthalmology at Harvard Medical School.

“Tissue preparation and device pre-loading by eye banks not only simplifies the surgery [but] may provide increased reproducible outcomes for endothelial keratoplasty,” said Dr. Pineda.

In a pre-clinical study presented at the 2012 Association for Research in Vision and Ophthalmology (ARVO) annual meeting, LEITR reported that eye banks are able to prepare and load corneal tissue safely into the cartridges; corneal buttons pre-loaded by LEITR sustained an average of 9.07% endothelial cell damage, compared with 36.2% in control group tissue that was loaded into the insertion system on site, a statistically significant difference (p = 0.004).

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.